Home / Petrochemicals / Xerostomia Global Clinical Trials Review, H1, 2015

Xerostomia Global Clinical Trials Review, H1, 2015

Published: Jun 2015 | No Of Pages: 79 | Published By: GlobalData

Xerostomia Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Xerostomia Global Clinical Trials Review, H1, 2015" provides an overview of Xerostomia clinical trials scenario. This report provides top line data relating to the clinical trials on Xerostomia . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Xerostomia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Xerostomia to Mouth And Dental Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Xerostomia to Mouth And Dental Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Xerostomia 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Xerostomia Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Boehringer Ingelheim GmbH 31
Clinical Trial Overview of Boehringer Ingelheim GmbH 31
Worldwide Clinical Trials, Inc. 32
Clinical Trial Overview of Worldwide Clinical Trials, Inc. 32
Parion Sciences, Inc. 33
Clinical Trial Overview of Parion Sciences, Inc. 33
Daiichi Sankyo Company, Limited 34
Clinical Trial Overview of Daiichi Sankyo Company, Limited 34
Acacia Pharma Limited 35
Clinical Trial Overview of Acacia Pharma Limited 35
GlaxoSmithKline Plc 36
Clinical Trial Overview of GlaxoSmithKline Plc 36
General Drugs House Co., Ltd. 37
Clinical Trial Overview of General Drugs House Co., Ltd. 37
CEDRA Corporation 38
Clinical Trial Overview of CEDRA Corporation 38
Camurus AB 39
Clinical Trial Overview of Camurus AB 39
Calabar AB 40
Clinical Trial Overview of Calabar AB 40
Clinical Trial Overview of Top Institutes / Government 41
Alberta Health Services 41
Clinical Trial Overview of Alberta Health Services 41
American Academy of Otolaryngology Head and Neck Surgery 42
Clinical Trial Overview of American Academy of Otolaryngology Head and Neck Surgery 42
Asan Medical Center 43
Clinical Trial Overview of Asan Medical Center 43
Centre Francois Baclesse 44
Clinical Trial Overview of Centre Francois Baclesse 44
Charite - Universitatsmedizin Berlin 45
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 45
Children's Hospital Boston 46
Clinical Trial Overview of Children's Hospital Boston 46
Dental Innovation Foundation 47
Clinical Trial Overview of Dental Innovation Foundation 47
Department of Health, UK 48
Clinical Trial Overview of Department of Health, UK 48
Erasmus MC 49
Clinical Trial Overview of Erasmus MC 49
Georgia Regents University 50
Clinical Trial Overview of Georgia Regents University 50
Five Key Clinical Profiles 51
Appendix 76
Abbreviations 76
Definitions 76
Research Methodology 77
Secondary Research 77
About GlobalData 78
Contact Us 78
Disclaimer 78
Source 79

List of Tables
Xerostomia Therapeutics, Global, Clinical Trials by Region, 2015* 7
Xerostomia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Xerostomia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Xerostomia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Xerostomia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Xerostomia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Xerostomia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Xerostomia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Xerostomia to Mouth And Dental Disorders Clinical Trials, G7 Countries (%), 2015* 15
Xerostomia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Xerostomia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Xerostomia to Mouth And Dental Disorders Clinical Trials, E7 Countries (%), 2015* 18
Xerostomia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Xerostomia Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Xerostomia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Xerostomia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Xerostomia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Xerostomia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24
Xerostomia Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Xerostomia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Xerostomia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Xerostomia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Xerostomia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Xerostomia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2015* 31
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Worldwide Clinical Trials, Inc., 2015* 32
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Parion Sciences, Inc., 2015* 33
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 34
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Acacia Pharma Limited, 2015* 35
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 36
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by General Drugs House Co., Ltd., 2015* 37
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by CEDRA Corporation, 2015* 38
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Camurus AB, 2015* 39
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Calabar AB, 2015* 40
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2015* 41
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by American Academy of Otolaryngology Head and Neck Surgery, 2015* 42
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 43
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Francois Baclesse, 2015* 44
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2015* 45
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital Boston, 2015* 46
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dental Innovation Foundation, 2015* 47
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015* 48
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2015* 49
Xerostomia Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgia Regents University, 2015* 50

List of Figures
Xerostomia Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Xerostomia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Xerostomia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Xerostomia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Xerostomia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Xerostomia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Xerostomia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Xerostomia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Xerostomia to Mouth And Dental Disorders Clinical Trials, G7 Countries (%), 2015* 15
Xerostomia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Xerostomia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Xerostomia to Mouth And Dental Disorders Clinical Trials, E7 Countries (%), 2015* 18
Xerostomia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Xerostomia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Xerostomia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Xerostomia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Xerostomia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Xerostomia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Xerostomia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Xerostomia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Xerostomia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Xerostomia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 77

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +